These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1916652)

  • 21. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
    Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of prolactin secretion in polycystic ovary syndrome.
    Murdoch AP; Dunlop W; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):165-75. PubMed ID: 3085993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced prolactin secretion in patients with primary hypothyroidism during thyroid replacement.
    Sato S; Hanew K; Sasaki A; Shimizu Y; Murakami O; Fukazawa H; Sakurada T; Saito S; Yoshinaga K
    Tohoku J Exp Med; 1984 Dec; 144(4):425-31. PubMed ID: 6528338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
    Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease.
    Szilágyi A; Hole R; Keckstein J; Rossmanith WG
    Gynecol Endocrinol; 1993 Sep; 7(3):159-66. PubMed ID: 8291452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Subclinical hypothyroidism and endocrine metabolic characteristics in women with polycystic ovary syndrome].
    Yue F; Zhang D; Gong F; Zhang L; Sun Z; Lei M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):940-946. PubMed ID: 28872086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulated thyrotropin and prolactin secretion in lactating and non-lactating women.
    Rossmanith WG; Hohl B; Lüttke B
    Gynecol Endocrinol; 1995 Sep; 9(3):181-8. PubMed ID: 8540286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased thyrotrophin secretion induced by sulpiride in man.
    Massara F; Camanni F; Belforte L; Vergano V; Molinatti GM
    Clin Endocrinol (Oxf); 1978 Nov; 9(5):419-28. PubMed ID: 569030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
    Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
    J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible altered dopaminergic modulation of pituitary function in normal-menstruating women with insulin dependent diabetes mellitus (IDDM).
    Djursing H; Carstensen L; Hagen C; Andersen AN
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):450-5. PubMed ID: 6440390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin response to N3im-methyl-thyrotropin releasing hormone in euthyroid subjects.
    Sowers JR; Hershman JM; Carlson HE; Pekary E; Nair MG; Baugh CM
    J Clin Endocrinol Metab; 1976 Oct; 43(4):749-55. PubMed ID: 824297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin secretion in polycystic ovary syndrome: circadian rhythmicity and dynamic aspects.
    Ferrari E; Bossolo PA; Foppa S; Dalzano M; Comis S; Morelli MP; Peveri V; Mengozzi A
    Gynecol Endocrinol; 1988 Jun; 2(2):101-11. PubMed ID: 3188970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of altered dopaminergic modulation of Prl, LH, FSH, GH and TSH secretion during chronic partial dopamine receptor blockade in normal women.
    Hagen C; Andersen AN; Djursing H
    Acta Endocrinol (Copenh); 1984 May; 106(1):1-7. PubMed ID: 6428112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome.
    Billa E; Kapolla N; Nicopoulou SC; Koukkou E; Venaki E; Milingos S; Antsaklis A; Adamopoulos DA
    Gynecol Endocrinol; 2009 Jul; 25(7):427-34. PubMed ID: 19533481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in plasma melanocyte-stimulating hormone, ACTH, prolactin, GH, LH, FSH, and thyroid-stimulating hormone in response to injection of sulpiride, thyrotropin-releasing hormone, or vehicle in insulin-sensitive and -insensitive mares.
    Valencia NA; Thompson DL; Mitcham PB
    Domest Anim Endocrinol; 2013 May; 44(4):204-12. PubMed ID: 23571008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperprolactinemia in polycystic ovary syndrome.
    Luciano AA; Chapler FK; Sherman BM
    Fertil Steril; 1984 May; 41(5):719-25. PubMed ID: 6425087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of pulsatile secretion of gonadotropin and prolactin in women with normal menstrual cycle, secondary amenorrhea and polycystic ovary syndrome (PCOS).
    Lin KC; Lee JN
    Kaohsiung J Med Sci; 1998 Feb; 14(2):61-7. PubMed ID: 9542361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.